Stock Search
Search for you Ticker
Find and analyze stocks with comprehensive financial metrics including P/E ratios, dividend yields, and growth indicators. Filter by sector, valuation metrics, and performance to identify investment opportunities.
Company Overview
RESMED INC
Health CareHealth Care EquipmentResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditio...
ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers (i.e. home health, hospice, skilled nursing facilities, life plan communities, senior living centers, and private duty).
Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024.
Exchange: NYSE
Company Statistics
Profile
Revenue$5.65B
Margins
Gross61.1%
Operating33.4%
Pre-Tax34%
Net26.9%
FCF29.2%
Returns (5Yr Avg)
ROA16.5%
ROE24.4%
ROCE22.4%
ROIC27.8%
Valuation (TTM)
Financial Health
Cash$1.47B
Net Debt-$1.21B
Debt/Equity0.0
Growth (CAGR)
Rev 3Yr10.2%
Rev 5Yr12.1%
Rev 10Yr11.9%
Dil EPS 3Yr19.6%
Dil EPS 5Yr26.3%
Dil EPS 10Yr15.4%
FCF 5Yr21.1%
Shares 5Yr-0.1%
Dividends
Yield1%
DPS$2.46
DPS Growth 3Yr0.4%
DPS Growth 5Yr2.8%
DPS Growth 10Yr4%
Price History
No price history available
Financial Performance
Display:
Data reported in USD
Assets vs Liabilities
Data reported in USD
Free Cash Flow
Data reported in USD